NP2 Enkephalin For Treatment of Intractable Cancer Pain
Public ClinicalTrials.gov record NCT01291901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double Blind, Placebo-controlled, Multicenter Study to Investigate the Impact of NP2 in Subjects With Intractable Pain Due to Malignancy
Study identification
- NCT ID
- NCT01291901
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Diamyd Inc
- Industry
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Interventions
- NP2 Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010
- Primary completion
- Jun 30, 2012
- Completion
- Oct 31, 2013
- Last update posted
- Aug 7, 2014
2011 – 2013
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HOPE Research Institute | Phoenix | Arizona | 85050 | — |
| Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| Compassionate Cancer Care Medical Group, Inc. | Corona | California | 92879 | — |
| Cancer Care Associates | Fresno | California | 93720 | — |
| TriWest Research Associates | La Mesa | California | 91942 | — |
| White Memorial Medical Center | Los Angeles | California | 90033 | — |
| Hematology Oncology Associates | Oakland | California | 94609 | — |
| Advanced Pharma CR | Miami | Florida | 33175 | — |
| Better Health Clinical Research Inc | Newnan | Georgia | 30265 | — |
| Christie Clinic | Champaign | Illinois | 61820 | — |
| Global Scientific Innovations | Evansville | Indiana | 47714 | — |
| Montana Cancer Institute Foundation | Missoula | Montana | 59802 | — |
| Center for Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Signal Point Clinical research Center | Middletown | Ohio | 45042 | — |
| Pain Research of Oregon | Eugene | Oregon | 97401 | — |
| Hematology Oncology Associatesof Rhode Island | Cranston | Rhode Island | 02920 | — |
| Medical Therapy and Research | San Antonio | Texas | 78217 | — |
| Medical Oncology Associates | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01291901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01291901 live on ClinicalTrials.gov.